Skip to main content

CombiMatrix Could Garner $2M in FY 2009 Defense Funds for Health Surveillance System

NEW YORK (GenomeWeb News) – CombiMatrix said today that proposed US military funding for fiscal year 2009 includes $2 million for the company to develop a health surveillance system.
 
Senator Patty Murray (D – Wash.) included the funding for Mukilteo, Wash.-based CombiMatrix as part of $72 million in federal defense work for Washington companies in the 2009 Defense Appropriations Bill, which passed the Senate Defense Appropriations Subcommittee on Sept. 10.
 
CombiMatrix said it will receive the funding if and when the bill passes, as long as the funds are not struck from the bill beforehand. 
 
The company would use the funding to work with the Air Force Research Laboratory to develop a semiconductor microarray and instrumentation platform to detect changes in body chemistry caused by traumas.
 
David Danley, director of homeland security and defense programs at Combimatrix, said in a statement that the company will “further develop its microarray platform technology to provide the military healthcare system with new tools for treating everything from bullet wounds to battlefield stress.”
 
The funding would enable the firm “to develop new assays on our microarray platform to identify changes in body chemistry and gene expression that are indicative of adverse changes in physiological performance,” Danley added.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.